Literature DB >> 16986512

[Study of L-02 hepatocyte apoptosis induced by hexavalent chromium associated with mitochondria function damage].

Jing-wei Xiao1, Cai-gao Zhong, Bin Li.   

Abstract

OBJECTIVE: To explore the effect of hexavalent chromium on apoptosis of L-02 hepatocytes and the functions of mitochondria. METHODS L-02 hepatocytes in all tests were incubated with 0,2,4,8,16,32 [see text] 64 micromol/L of Cr(VI) for 6h. Apoptosis of L-02 hepatocytes in the presence of Cr(VI) was quantified by flow cytometry (FCM). The permeability transition pore (FTP) of mitochondria and mitochondrial membrane potential as indicators of mitochondrial damage were measured by fluorescent spectrometer.
RESULTS: Concentration-dependent decrease in cell apoptosis rate of Cr(VI)-treated L-02 hepatocytes were observed. The results of permeability transition pore (PTP) of mitochondria, mitochondrial membrane potential in all concentrations of Cr(VI) had significant difference when compared to the control cells (P < 0.05).
CONCLUSION: The results demonstrated that L-02 hepatocytes apoptosis induced by Cr(VI) associated with mitochondrial damages.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16986512

Source DB:  PubMed          Journal:  Wei Sheng Yan Jiu        ISSN: 1000-8020


  2 in total

1.  Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity, and membrane permeability transition pore opening.

Authors:  Wylly Ramsés García-Niño; Edilia Tapia; Cecilia Zazueta; Zyanya Lucía Zatarain-Barrón; Rogelio Hernández-Pando; Claudia Cecilia Vega-García; José Pedraza-Chaverrí
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-17       Impact factor: 2.629

2.  Chi-square analysis of the reduction of ATP levels in L-02 hepatocytes by hexavalent chromium.

Authors:  Yang Yuan; Li Peng; Hu Gong-Hua; Dai Lu; Zhong Xia-Li; Zhou Yu; Zhong Cai-Gao
Journal:  Braz J Med Biol Res       Date:  2012-03-22       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.